Fixed ceiling prices of 849 formulations till November 2017: Govt informs Parliament

The government has fixed ceiling prices of 849 formulations, including two coronary stents, till November 2017, Parliament was informed

india Updated: Dec 15, 2017 18:09 IST
Press Trust of India
Press Trust of India
Press Trust of India, New Delhi
Parliament,Formulations,Coronary stents
New Delhi, India- Dec 15, 2017: A general view of the Parliament House on the first day of the Parliament winter session in New Delhi, India on Friday. December 15, 2017. ( Photo by Sonu Mehta/ Hindustan Times)(Sonu Mehta/HT PHOTO)

The government has fixed ceiling prices of 849 formulations, including two coronary stents, till November 2017, Parliament was informed on Friday.

The government has fixed the ceiling prices of 849 formulations, including two coronary stents, under revised Schedule I, based on National List of Essential Medicines, 2015,” Minister of State for Chemicals & Fertilisers Mansukh L Mandaviya said in a written reply in Rajya Sabha.

The National Pharmaceuticals Pricing Authority (NPPA) fixes the ceiling prices of medicines listed in the Drugs (Prices Control) Order, 2013 (DPCO 2013), he added.

Out of the 849 formulations, the ceiling prices of 59 formulations were reduced by above 40 per cent with respect to maximum price, Mandaviya said.

In case of 24 formulations, the slab wise percentage reduction with respect to maximum price was between 35-40 per cent, he added.

The prices of 233 formulations were reduced by up to five per cent, Mandaviya said.

First Published: Dec 15, 2017 18:08 IST